Mutual Fund Details
NAV
₹20.6000
as on 19 Apr 2024, 11:15 PM
₹-0.0900(0.43%)
Last Change
Scheme Ratings
2
rated by Value Research
Pharma
Rankings based on | as on Invalid date
×
Schemes Managed By
Investment Performance
would have given a return of
₹1,10,871
₹1,21,647
₹1,49,420
₹1,56,148
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹56,148
Profit (absolute return)
56.15%
in the last
1m
3m
1y
3y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
5.06%
In the last 6 months
22.57%
In the last 1 year
54.24%
In the last 3 years
56.15%
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low to moderate
moderate
moderately high
high
very high
Investors understand that their principal will be at very high risk
Scheme Information
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW Reinvestment
as of 31 Mar 2024, 05:30 AM
₹699.55 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 30 days.
1.04%
Expense Ratio
Plan
Dividend
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 30 days.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Mar 2024
Healthcare
89.70%
₹627.50 Cr
Insurance
1.90%
₹13.28 Cr
Services
1.04%
₹7.26 Cr
Chemicals
0.40%
₹2.79 Cr
Others
6.96%
₹48.69 Cr
Companies Holding in this Mutual Fund
as on 31 Mar 2024
Sun Pharmaceutical Industries Ltd.
15.74%
₹110.11 Cr
Cipla Ltd.
8.31%
₹58.13 Cr
Torrent Pharmaceuticals Ltd.
7.24%
₹50.65 Cr
Apollo Hospitals Enterprise Ltd.
6.72%
₹47.01 Cr
Others
61.99%
₹433.65 Cr
View All
View All
This fund's returns:
15.97%Return Duration
3 Years
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
12.49%
19.26%
3Y Returns
19.26
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
12.49%
19.26%
3Y Returns
18.73
Tata India Pharma & HealthCare Fund Direct-Growth
EquityPharma
Min. Investment
₹100
Category Returns
12.49%
19.26%
3Y Returns
18.15
About Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW Reinvestment
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW Reinvestment is a Equity mutual fund scheme from Aditya Birla Sun Life Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Dhaval Shah. It has an AUM of ₹699.55 Crores and the latest NAV decalared is ₹20.600 as on 20 Apr 2024 at 3:41 am.
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-IDCW Reinvestment scheme return performance in last 1 year is 54.24%, in last 3 years is 56.15% and 176.64% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
| AUM: | ₹699.55 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
Aditya Birla Sun Life Mutual Fund
View AMC Details
₹3,14,892.04 Cr
AUM
187
Schemes
Address
One World Center, Tower 1, 17th Floor, Jupiter Mill CompoundSenapati Bapat Marg, Elphinstone Road400013
Phone Number
Fax : 022-43568110
Email / Website
Start investing in minutes
Download app to Explore
Scan this QR code to download the app now!
Or download from
